RELUGOLIX COMBINATION THERAPY SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS WITH FIRST TREATMENT CYCLE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM.

被引：0

作者：

Venturella, Roberta ^{[1
]}

Al-Hendy, Ayman ^{[2
]}

Lukes, Andrea S. ^{[3
]}

Kang, Jennifer ^{[4
]}

McKain, Laura ^{[4
]}

Stewart, Elizabeth A. ^{[5
]}

机构：

[1] Magna Graecia Univ Catanzaro, Catanzaro, Italy

[2] Univ Illinois, Dept Surg, Chicago, IL 60680 USA

[3] Carolina Womens Res & Wellness Ctr, Durham, NC USA

[4] Myovant Sci Inc, Brisbane, CA USA

[5] Mayo Clin, Dept OB GYN Reprod Endocrinol & Infertil, Rochester, MN USA

来源：

FERTILITY AND STERILITY | 2020年 / 114卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

O-206

引用

页码：E85 / E85

页数：1

共 24 条

[1] QUALITY-OF-LIFE IMPROVEMENT WITH RELUGOLIX COMBINATION THERAPY IN PATIENTS WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM.
Al-Hendy, Ayman
Stewart, Elizabeth A.
Venturella, Roberta
Poindexter, Alfred, III
Villarroel, Claudio
Kang, Jennifer
Wagman, Rachel B.
Hunsche, Elke
Lukes, Andrea S.
FERTILITY AND STERILITY, 2020, 114 (03) : E85 - E85
[2] Relugolix combination therapy improves hemoglobin levels in anemic women with heavy menstrual bleeding due to uterine fibroids: results from the LIBERTY Phase 3 program
Venturella, R.
Stewart, E. A.
Al-Hendy, A.
Kang, J.
McKain, L.
Lukes, A.
HUMAN REPRODUCTION, 2020, 35 : 11 - 11
[3] LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids
Al-Hendy, Ayman
Venturella, Roberta
Ferreira, Juan Camilo Arjona
Li, Yulan
Soulban, Graziella
Wagman, Rachel B.
Lukes, Andrea S.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 229 (06) : 662.e1 - 662.e25
[4] RELUGOLIX COMBINATION THERAPY IMPROVES UTERINE FIBROID-ASSOCIATED PAIN DURING MENSTRUAL AND NON-MENSTRUAL DAYS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM.
Al-Hendy, Ayman
Lukes, Andrea S.
Venturella, Roberta
Li, Yulan
Wagman, Rachel B.
Hunsche, Elke
Stewart, Elizabeth A.
FERTILITY AND STERILITY, 2020, 114 (03) : E232 - E232
[5] LIBERTY RANDOMIZED WITHDRAWAL STUDY: 2-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
Al-Hendy, Ayman
Venturella, Roberta
Ferreira, Juan Camilo Arjona
Li, Yulan
Wagman, Rachel B.
Lukes, Andrea S.
FERTILITY AND STERILITY, 2021, 116 (03) : E2 - E2
[6] An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women
Ali, Mohamed
Chen, Hsin-Yuan
Chiang, Yi-Fen
Badary, Osama A.
Hsia, Shih-Min
Al-Hendy, Ayman
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (04) : 421 - 429
[7] EFFECTS OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY THROUGH 2 YEARS IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
McClung, Michael R.
Lukes, Andrea S.
Venturella, Roberta
Santora, Arthur C.
Zhai, Dongmei
Wagman, Rachel B.
Al-Hendy, Ayman
FERTILITY AND STERILITY, 2021, 116 (03) : E13 - E13
[8] Relugolix Combination Therapy-Preserves Bone Mass in Patients with Uterine Fibroids: Results from Phase 3 LIBERTY Program
McClung, Michael R.
Santora, Arthur
Al-Hendy, Ayman
McKain, Laura
Li, Yulan
Wagman, Rachel B.
JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 246 - 246
[9] Elagolix Reduced Heavy Menstrual Bleeding With Uterine Fibroids: Primary, 6-Month, Phase 3 Results
Schlaff, William
Al-Hendy, Ayman
Barnhart, Kurt
Owens, Charlotte D.
Liu, Ran
Muneyyirci-Delale, Ozgul
OBSTETRICS AND GYNECOLOGY, 2019, 133 : 9S - 9S
[10] TREATMENT PATTERNS IN WOMEN WITH UTERINE FIBROIDS AND HEAVY MENSTRUAL BLEEDING: RESULTS FROM A LARGE UF CLAIMS DATABASE
McKain, L.
Edsall, K.
Lickert, C.
VALUE IN HEALTH, 2020, 23 : S543 - S543

← 1 2 3 →